<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03818230</url>
  </required_header>
  <id_info>
    <org_study_id>NHS001389</org_study_id>
    <nct_id>NCT03818230</nct_id>
  </id_info>
  <brief_title>An Evaluation of the Psychological Impact of Early Phase Clinical Trials in Cancer Patients.</brief_title>
  <acronym>EPIC</acronym>
  <official_title>An Evaluation of the Psychological Impact of Early Phase Clinical Trials in Cancer Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manchester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Christie NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Manchester</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an exploratory prospective observational cohort study to establish the levels of
      psychological distress in early phase clinical trial patients and evaluate the psychological
      impact of early phase clinical trials on cancer patients. Participants will be requested to
      complete self-reported questionnaires, measuring levels of anxiety, depression and hope, at
      different time points along the clinical trials pathway.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 21, 2018</start_date>
  <completion_date type="Actual">November 15, 2019</completion_date>
  <primary_completion_date type="Actual">November 15, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Levels of anxiety and depression as per the Hospital Anxiety and Depression Scale questionnaire.</measure>
    <time_frame>Approximately 14 weeks.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Levels of hope as per the Adult Hope Scale.</measure>
    <time_frame>Approximately 14 weeks.</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">64</enrollment>
  <condition>Cancer</condition>
  <condition>Depression</condition>
  <condition>Anxiety</condition>
  <condition>Hope</condition>
  <condition>Psychological Distress</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>None (observational study)</intervention_name>
    <description>None (observational study)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have been referred to the Experimental Cancer Medicine Team (ECMT) at The
        Christie NHS Foundation Trust, to be considered for participation in an early phase
        clinical trial.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18 years and older

          -  Able to provide informed consent

          -  Are being considered for an early phase clinical trial

        Exclusion Criteria:

          -  Patients unable to comprehend English language
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Christie NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <state>Greater Manchester</state>
        <zip>M20 4BX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 17, 2019</study_first_submitted>
  <study_first_submitted_qc>January 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2019</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Manchester</investigator_affiliation>
    <investigator_full_name>Dr Natalie Cook</investigator_full_name>
    <investigator_title>Honorary Consultant in Medical Oncology</investigator_title>
  </responsible_party>
  <keyword>Clinical trials</keyword>
  <keyword>Early phase clinical trials</keyword>
  <keyword>Experimental cancer medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

